PAR 6.12% 26.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-51

  1. 763 Posts.
    lightbulb Created with Sketch. 141
    Interestingly, it appears we had a paradoxical drug reaction (increase in OA signs) with the lower dose.

    I hope the idea of testing the 2mg/kg 1x/wk and lower doses has disappeared forever. It has been a huge time and money waster - thanks FDA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.